JNJ-64619178 potently reduced cell viability in both MYCN-amplified and non-amplified neuroblastoma cell lines, apart from SK-N-F1, compared to the normal fibroblast cell line (Fig. 6A and Supplementary Table 3). The gene discussed is MYCN; the disease is neuroblastoma.